Skip to main content
SpringerLink
Log in

Primary aldosteronism: A needle in a haystack or a yellow cab on fifth avenue?

  • Invited Commentary
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Conn JW: Part I. Painting background. Part II. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1990, 116:253–267.

    PubMed  CAS  Google Scholar 

  2. Conn JW: Primary aldosteronism. In Hypertension: Pathophysiology and Treatment, edn 1. Edited by Genest O, Harnet P. New York: McGraw-Hill, 1977:768–780.

    Google Scholar 

  3. Conn JW: Plasma renin activity in primary aldosteronism. JAMA 1964, 190:222–225.

    PubMed  CAS  Google Scholar 

  4. Conn JW, Cohen EL, Rovner DR, Nesbit RM: Normokalemic primary aldosteronism: a detectable cause of curable "essential" hypertension. JAMA 1965, 193:200–206.

    PubMed  CAS  Google Scholar 

  5. Conn JW, Rovner DR, Cohen EL, Nesbit RM: Normokalemic primary aldosteronism: its masquerade as "essential" hypertension. JAMA 1966, 195:21–26.

    Article  Google Scholar 

  6. Kaplan NM: The incidence of primary aldosteronism in patients with "essential" hypertension. J Lab Clin Med 1965, 66:883–884.

    Google Scholar 

  7. Kaplan NM: The incidence of primary aldosteronism in patients with "essential" hypertension. J Clin Invest 1966, 45:1031–1032.

    Google Scholar 

  8. Kaplan NM: Commentary on incidence of primary aldosteronism: current estimations based on objective data. Arch Intern Med 1969, 123:152–154.

    Article  PubMed  CAS  Google Scholar 

  9. Conn JW: A concluding response. Arch Intern Med 1969, 123:154–155.

    Article  PubMed  CAS  Google Scholar 

  10. Gordon RD, Ziesak MD, Tunny TJ, et al.: Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993, 20:296–298.

    PubMed  CAS  Google Scholar 

  11. Anderson GH Jr, Blakeman N, Streeten DH: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994, 12:609–615.

    Article  PubMed  Google Scholar 

  12. Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315–318.

    PubMed  CAS  Google Scholar 

  13. Abdelhamid S, Muller LH, Pahl S, et al.: Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch Intern Med 1996, 156:1190–1195.

    Article  PubMed  CAS  Google Scholar 

  14. Brown MA, Cramp HA, Zammit VC, Whitworth JA: Primary hyperaldosteronism: a missed diagnosis in ‘essential hypertensives’? Aust N Z J Med 1996, 26:533–538.

    PubMed  CAS  Google Scholar 

  15. Rossi GP, Rossi E, Pavan E, et al.: Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol Oxf 1998, 49:713–723.

    Article  PubMed  CAS  Google Scholar 

  16. Mosso L, Fardella C, Montero J, et al.: [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Rev Med Chil 1999, 127:800–806.

    PubMed  CAS  Google Scholar 

  17. Rayner BL, Opie LH, Davidson JS: The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J 2000, 90:394–400.

    PubMed  CAS  Google Scholar 

  18. Loh KC, Koay ES, Khaw MC, et al.: Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85:2854–2859.

    Article  PubMed  CAS  Google Scholar 

  19. Denolle T, Hanon O, Mounier-Vehier C, et al.: [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?]. Arch Mal Coeur Vaiss 2000, 93:1037–1039.

    PubMed  CAS  Google Scholar 

  20. Cortes P, Fardella C, Oestreicher E, et al.: [Excess of mineralocorticoids in essential hypertension: clinicaldiagnostic approach]. Rev Med Chil 2000, 128:955–961.

    PubMed  CAS  Google Scholar 

  21. Nishikawa T, Omura M: Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 2000, 54(Suppl 1):83s-85s.

    Article  PubMed  Google Scholar 

  22. Fardella CE, Mosso L, Gomez-Sanchez C, et al.: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000, 85:1863–1867.

    Article  PubMed  CAS  Google Scholar 

  23. Lim PO, Dow E, Brennan G, et al.: High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000, 14:311–315.

    Article  PubMed  CAS  Google Scholar 

  24. Rayner BL, Myers JE, Opie LH, et al.: Screening for primary aldosteronism: normal ranges for aldosterone and renin in three South African population groups. S Afr Med J 2001, 91:594–599.

    PubMed  CAS  Google Scholar 

  25. Calhoun DA, Nishizaka MK, Zaman MA, et al.: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002, 40:892–896.

    Article  PubMed  CAS  Google Scholar 

  26. Rossi E, Regolisti G, Negro A, et al.: High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 2002, 15:896–902.

    Article  PubMed  CAS  Google Scholar 

  27. Schwartz GL, Chapman AB, Boerwinkle E, et al.: Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem 2002, 48:1919–1923.

    PubMed  CAS  Google Scholar 

  28. Bravo EL: Secondary hypertension: a streamlined approach to diagnosis. Postgrad Med 1986, 80:139–151.

    PubMed  CAS  Google Scholar 

  29. Halimi JM, Mimran A: Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995, 13:1801–1802.

    PubMed  CAS  Google Scholar 

  30. Nishimura M, Uzu T, Fujii T, et al.: Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999, 33:261–266.

    PubMed  CAS  Google Scholar 

  31. Takeda R, Matsubara T, Miyamori I, et al.: Vascular complications in patients with aldosterone-producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. J Endocrinol Invest 1995, 18:370–373.

    PubMed  CAS  Google Scholar 

  32. Suzuki T, Abe H, Nagata S, et al.: Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. Am J Cardiol 1988, 62:1224–1227.

    Article  PubMed  CAS  Google Scholar 

  33. Denolle T, Chatellier G, Julien J, et al.: Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. Am J Hypertens 1993, 6:907–913.

    PubMed  CAS  Google Scholar 

  34. Rossi GP, Sacchetto A, Visentin PA, et al.: Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996, 27:1039–1045.

    PubMed  CAS  Google Scholar 

  35. Shigematsu Y, Hamada M, Okayama H, et al.: Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997, 29:723–727.

    PubMed  CAS  Google Scholar 

  36. Rossi GP, Sacchetto A, Pavan E, et al.: Remodeling of the left ventricle in primary aldosteronism due to Conn’s adenoma. Circulation 1997, 95:1471–1478.

    PubMed  CAS  Google Scholar 

  37. Rossi G, Rossi A, Zanin L, et al.: Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism. Am J Hypertens 1993, 6:8–14.

    PubMed  CAS  Google Scholar 

  38. Rizzoni D, Porteri E, Castellano M, et al.: Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998, 31:335–341.

    PubMed  CAS  Google Scholar 

  39. Rizzoni D, Muiesan ML, Porteri E, et al.: Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998, 32:985–992.

    Article  PubMed  CAS  Google Scholar 

  40. Campbell SE, Diaz-Arias AA, Weber KT: Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1992, 1:149–156.

    PubMed  CAS  Google Scholar 

  41. Rossi GP, Di Bello V, Ganzaroli C, et al.: Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002, 40:23–27.

    Article  PubMed  CAS  Google Scholar 

  42. Kozakova M, Buralli S, Palombo C, et al.: Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003, 41:230–236.

    Article  PubMed  CAS  Google Scholar 

  43. Rossi GP, Sacchetto A, Pavan E, et al.: Left ventricular systolic function in primary aldosteronism and hypertension. J Hypertens 1997, 19 (Suppl8):S147-S151.

    Google Scholar 

  44. Brilla CG, Pick R, Tan LB, et al.: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990, 67:1355–1364.

    PubMed  CAS  Google Scholar 

  45. Brilla CG, Maisch B, Rupp H, et al.: Pharmacological modulation of cardiac fibroblast function. Herz 1995, 20:127–134.

    PubMed  CAS  Google Scholar 

  46. Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  47. Pitt B, Remme W, Zannad F, et al.: Eplerenone: a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309–1321.

    Article  PubMed  CAS  Google Scholar 

  48. Rossi GP, Chiesura Corona M, et al.: Imaging of aldosteronesecreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J HumHypertens 1993, 7:357–363.

    CAS  Google Scholar 

  49. Rossi GP, Chiesura-Corona M, Gregianin M: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1995, 123:73–74.

    PubMed  CAS  Google Scholar 

  50. Scoggins BA, Oddie CJ, Hare WSC, Coghlan JP: Preoperative lateralisation of aldosterone-producing tumours in primary aldosteronism. Ann Intern Med 1972, 76:891–897.

    PubMed  CAS  Google Scholar 

  51. Rossi GP, Sacchetto A, Chiesura-Corona M, et al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86:1083–1090.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DMCS-Clinica Medica 4, University Hospital, via Giustiniani, 2, 35126, Padova, Italy

    Gian Paolo Rossi MD, FACC, FAHA

Authors
  1. Gian Paolo Rossi MD, FACC, FAHA
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rossi, G.P. Primary aldosteronism: A needle in a haystack or a yellow cab on fifth avenue?. Current Science Inc 6, 1–4 (2004). https://doi.org/10.1007/s11906-004-0001-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-004-0001-0

Keywords

Search

Navigation